Mountain View

DrChrono Integration with IntelliH Brings Advanced Remote Patient Monitoring (RPM) to DrChrono Platform

Retrieved on: 
Tuesday, September 21, 2021
Software as a service, Decompensation, ER, Tablet, IOS, DrChrono, Heart failure, Platform, Practice management, Solution, Thermometer, Glucose meter, API, HIPAA, Patient, Physician, Health, Diabetes, Caregiver, Android, Hypertension, RPM, Bluetooth, CEO, EHR, Architecture, CHF, COO, Conditional sentence, Industry, GLOBE, Pharmaceutical industry, Health insurance

SUNNYVALE, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- DrChrono Inc. , the company developing the essential platform and services for modern medical practices, announced today that IntelliH s turn-key remote patient monitoring solutions are now integrated with the DrChrono medical platform.

Key Points: 
  • SUNNYVALE, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- DrChrono Inc. , the company developing the essential platform and services for modern medical practices, announced today that IntelliH s turn-key remote patient monitoring solutions are now integrated with the DrChrono medical platform.
  • IntelliH, a cloud-based SaaS solution based on a HIPAA compliant architecture, enables secure access for care teams, patients and caregivers.
  • IntelliH is an Enterprise level multi-disease, patient engagement and digital health monitoring platform for chronic disease and post-discharged inpatients.
  • The platform is facilitating millions of patient appointments and is processing billions of dollars in medical billing.

El Camino Health Announces $3.5 Million in Grants and Sponsorships to Support Local Health Initiatives in Fiscal Year 2022

Retrieved on: 
Tuesday, September 21, 2021
Magnet, FQHC, MA, Language, Centers for Medicare & Medicaid Services, Elective surgery, AACI, Health, Mountain View, Hospital, Cancer, Income, Medicare, Patient, CMS, Asian Americans, Physician, Domestic violence, Heart, Diabetes, CEO, Community benefits agreement, Neurology, Dementia, Housing, Community, American Nurses Credentialing Center, Center, Technology, Obesity, Urology, Education, Spine, Dentistry, Health insurance, Medicine

MOUNTAIN VIEW, Calif., Sept. 21, 2021 /PRNewswire/ -- El Camino Health is using its Community Benefit Program to providefoundational support for local health initiatives byinvesting$3.5 million in grantsand sponsorships in fiscal year 2022.

Key Points: 
  • MOUNTAIN VIEW, Calif., Sept. 21, 2021 /PRNewswire/ -- El Camino Health is using its Community Benefit Program to providefoundational support for local health initiatives byinvesting$3.5 million in grantsand sponsorships in fiscal year 2022.
  • As El Camino Health celebrates its 60thanniversary ,it is continuing to act on the belief that a healthy community benefitsall.
  • Every three years, El Camino Health collaborates with other local not-for-profit hospitals and health systems to conduct a Community Health Needs Assessment (CHNA).
  • El Camino Health has earned four consecutive American Nurses Credentialing Center Magnet Recognitions for nursing excellence and quality patient care.

Pactum, the creator of autonomous negotiation technology, wins the prestigious Digital Procurement World 2021 Startup Competition

Retrieved on: 
Monday, September 20, 2021
Efficiency, Government of Estonia, ROI, Mountain View, Engineering, Cognitive science, Automation, SAN, DPW, DEMO, Technology, Human, Fortune 500, Organization, Walmart, Starship Technologies, Digital, Retail, Sales

SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ -- Pactum, the creator of autonomous negotiations, has won in the Automation & Efficiency category in this year's edition of Digital Procurement World's DEMO Startup Competition. This prestigious award recognizes those startups driving procurement's digital transformation and generating the highest ROI for organizations worldwide.

Key Points: 
  • SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ -- Pactum, the creator of autonomous negotiations, has won in the Automation & Efficiency category in this year's edition of Digital Procurement World's DEMO Startup Competition.
  • This prestigious award recognizes those startups driving procurement's digital transformation and generating the highest ROI for organizations worldwide.
  • "The majority of companies' investment goes into dealing with a small group of their suppliers.
  • "Pactum's autonomous negotiations help procurement professionals automate and streamline repetitive processes and manual tasks to increase efficiency, improve accuracy and create value," highlights Matthias Gutzmann, founder of Digital Procurement World (DPW).

Pactum, the creator of autonomous negotiation technology, wins the prestigious Digital Procurement World 2021 Startup Competition

Retrieved on: 
Monday, September 20, 2021
Efficiency, Government of Estonia, ROI, Mountain View, Engineering, Cognitive science, Automation, SAN, DPW, DEMO, Technology, Human, Fortune 500, Organization, Walmart, Starship Technologies, Digital, Retail, Sales

SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ -- Pactum, the creator of autonomous negotiations, has won in the Automation & Efficiency category in this year's edition of Digital Procurement World's DEMO Startup Competition. This prestigious award recognizes those startups driving procurement's digital transformation and generating the highest ROI for organizations worldwide.

Key Points: 
  • SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ -- Pactum, the creator of autonomous negotiations, has won in the Automation & Efficiency category in this year's edition of Digital Procurement World's DEMO Startup Competition.
  • This prestigious award recognizes those startups driving procurement's digital transformation and generating the highest ROI for organizations worldwide.
  • "The majority of companies' investment goes into dealing with a small group of their suppliers.
  • "Pactum's autonomous negotiations help procurement professionals automate and streamline repetitive processes and manual tasks to increase efficiency, improve accuracy and create value," highlights Matthias Gutzmann, founder of Digital Procurement World (DPW).

Frequence Earns First Great Place to Work Certification™

Retrieved on: 
Wednesday, September 15, 2021
Workplace, Automation, Investment, AI, CEO, Technology, Great Places, Software, Advertising, Place, Industry, Certification, GLOBE, Intelligence, Feedback, Management, Mobile phone

This year, 88% of employees said it's a great place to work - 49% higher than the average U.S company.

Key Points: 
  • This year, 88% of employees said it's a great place to work - 49% higher than the average U.S company.
  • Great Place to Work Certification isnt something that comes easily it takes ongoing dedication to the employee experience, saidSarah Lewis-Kulin, vice president of global recognition at Great Place to Work.
  • We are honored to be recognized as a great place to work alongside so many remarkably innovative businesses, said Tom Cheli, CEO of Frequence.
  • According to Great Place to Work research , job seekers are 4.5 times more likely to find a great boss at a Certified great workplace.

Relyance AI Emerges From Stealth With $30M in Funding to Give Privacy Pros Real-Time Insights Into Their Codebase

Retrieved on: 
Wednesday, September 15, 2021
Network, Future, LLP, CEO, Menlo Ventures, VP, Private practice, Traceability, Poquita Ropa, API, CCPA, Privacy, Engineering, Former, MLOps, IPO, Harness, VMware, NLP, Language, CTO, Machine learning, GLOBE, Compliance, Organization, Acquisition, Cooley, Network Advertising Initiative, Microsoft, Movement, CA, GTM, Series, Saṃsāra, DSAR, Future of Privacy Forum, GDPR, QA, Trust, MongoDB, DevOps, Adaptive Insights, Security, Patreon, Marketing, ML, Risk, Cooley LLP, McKinsey & Company, Industry, RSA, IEEE Security & Privacy, Dialling (telephony), AppDynamics, Online shopping, Satellite navigation device, Medical device

Relyance AI is the first Privacy and Data Governance Ops solution to offer transparency and visibility all the way down to the source code in real-time.

Key Points: 
  • Relyance AI is the first Privacy and Data Governance Ops solution to offer transparency and visibility all the way down to the source code in real-time.
  • Relyance AI answers a problem the whole privacy industry is facing: Its six oclock - do you know where your data is?
  • Intelligent Insights: Relyance AI sends alerts about potential issues so privacy, data governance, and compliance teams can quickly prioritize action items.
  • Relyance AI unites these teams, giving them a common platform that ensures robust data privacy and continued trust in the brand.

MEDIA ALERT: Visit Andes Technology Corp. On-Line or In Person at the AI Hardware Summit Next Week

Retrieved on: 
Thursday, September 9, 2021

What: The 2021 AI Hardware Summit is a virtual and in-person conference focusing on systems-level optimizations for specific AI workloads and results from novel AI acceleration technologies.

Key Points: 
  • What: The 2021 AI Hardware Summit is a virtual and in-person conference focusing on systems-level optimizations for specific AI workloads and results from novel AI acceleration technologies.
  • Andes Technology will hold a virtual roundtable discussion, Thursday September 16 at 11:00 AM entitled "RISC-V Vector Processor Functionality for Large Scale Deep Learning Accelerators."
  • Roundtable participants will include John Min, Director of AE and Thang Tran, Principal Architect at Andes Technology Corp. and Dave Baker, Vice President of Digital Design at Luminous Computing.
  • Why: Andes Technology Corp.s innovative configurable RISC-V platform solution is enabling designers to create unique, highly optimized system architectures and hardware/software partitioning, that shorten time-to-market and increase design quality.

Veranome Biosystems Launches Next Wave of Innovation with Release of High Throughput Spatial Analyzer

Retrieved on: 
Thursday, September 9, 2021

MOUNTAIN VIEW, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Veranome Biosystems today announced commercial availability of the VSA-1 instrument for highly multiplexed, single cell spatial analysis.

Key Points: 
  • MOUNTAIN VIEW, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Veranome Biosystems today announced commercial availability of the VSA-1 instrument for highly multiplexed, single cell spatial analysis.
  • High-resolution, highly multiplexed spatial omics hold tremendous promise to accelerate medical research and enable the next wave of precision medicine, said Jim Dietz, President of Veranome Biosystems.
  • Product release timing: Initial customer installations are being scheduled for calendar Q4 2021 with full release and production ramp planned for calendar Q2 2022.
  • Veranome Biosystems LLC, an Applied Materials company, provides the spatial analysis market with a reliable, easy-to-use, end-to-end multi-omics solution.

Underdog Pharmaceuticals Awarded ‘Innovation Passport’ by UK Regulators

Retrieved on: 
Wednesday, September 8, 2021

MOUNTAIN VIEW, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Underdog Pharmaceuticals, Inc. (Underdog), a pre-clinical stage pharmaceutical company focusing on the treatment and reversal of age-related diseases, has been awarded an Innovation Passport under the United Kingdoms Innovative Licensing and Access Pathway (ILAP), to pursue fast patient access to its groundbreaking treatment for cardiovascular disease.

Key Points: 
  • MOUNTAIN VIEW, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Underdog Pharmaceuticals, Inc. (Underdog), a pre-clinical stage pharmaceutical company focusing on the treatment and reversal of age-related diseases, has been awarded an Innovation Passport under the United Kingdoms Innovative Licensing and Access Pathway (ILAP), to pursue fast patient access to its groundbreaking treatment for cardiovascular disease.
  • Underdog is one of the first companies, and UDP-003 one of the very few pre-clinical therapies, to receive an ILAP designation.
  • This is an honor for us and a wonderful step forward for our program, said Matthew S. OConnor, Underdog CEO of Scientific Affairs.
  • Underdog Pharmaceuticals, Inc., is pursuing a mission to treat the underlying causes of age-related disease.

DGAP-News: Kizoo Portfolio Company Underdog Awarded 'Innovation Passport' by UK Regulators

Retrieved on: 
Wednesday, September 8, 2021

This will enable faster patient access to Underdog's potentially groundbreaking treatment option for the prevention of heart attacks and stroke.

Key Points: 
  • This will enable faster patient access to Underdog's potentially groundbreaking treatment option for the prevention of heart attacks and stroke.
  • The ILAP program also provides the potential for significant downstream regulatory advantages, including rolling clinical reviews, accelerated assessment, and supervised early reimbursed use under adaptive authorization.
  • Underdog is developing engineered cyclodextrins for the treatment of atherosclerosis by removing arterial plaque to clear the non-degradable cholesterol that accumulates within cells in the arterial walls.
  • "I believe the MHRA is sending a powerful message by reviewing and admitting preclinical stage programs like ours into ILAP," noted Mike Kope, Underdog Co-CEO.